Comparison of Fibrin Monomers and D-dimers to predict thrombotic events in critically ill patients with COVID-19 pneumonia: A retrospective study
Abstract
Coronavirus disease 2019 (COVID-19) is associated with a high risk of thrombotic events, particularly in critically ill patients. Anticoagulants at higher than standard thromboprophylaxis doses have been advocated by our group [1]. Although higher doses may help reduce thrombotic complications, the risk of hemorrhage could limit the benefit of such a strategy unless individualized to high thrombotic risk patients. D-dimers have been extensively studied in COVID-19, and elevated levels are associated with increased mortality,
Domains
Life Sciences [q-bio]
Fichier principal
Comparison of Fibrin Monomers and D.pdf (204.3 Ko)
Télécharger le fichier
mmc2.pdf (198.77 Ko)
Télécharger le fichier
| Origin | Files produced by the author(s) |
|---|